David Angulo Gonzalez
Vorstandsvorsitzender bei SCYNEXIS, INC.
Vermögen: 705 410 $ am 30.04.2024
Aktive Positionen von David Angulo Gonzalez
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
SCYNEXIS, INC. | Direktor/Vorstandsmitglied | 01.01.2023 | - |
Vorstandsvorsitzender | 01.01.2023 | - | |
Präsident | 01.01.2023 | - | |
Technik-/Wissenschafts-/F&E-Leiter | 01.06.2015 | 01.01.2023 |
Karriereverlauf von David Angulo Gonzalez
Ehemalige bekannte Positionen von David Angulo Gonzalez
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Brickell Subsidiary, Inc.
Brickell Subsidiary, Inc. Pharmaceuticals: MajorHealth Technology Brickell Subsidiary, Inc. operates as a clinical-stage pharmaceutical company. It focuses on the development of differentiated, innovative drug therapies for the treatment of skin diseases. The firm specializes in Hyperhidrosis, Cutaneous T-Cell Lymphoma and Psoriasis areas. The company was founded by Reginald L. Hardy and Andrew D. Sklawer in November 2009 and is headquartered in Boulder, CO. | Technik-/Wissenschafts-/F&E-Leiter | 01.10.2010 | 01.05.2015 |
Stiefel Laboratories, Inc.
Stiefel Laboratories, Inc. Pharmaceuticals: MajorHealth Technology Stiefel Laboratories, Inc. engages in the manufacture of pharmaceutical products. It offers prescription and non-prescription dermatological and skin care products. The firm research, innovate and develop skin care treatments to health care professionals, patients and consumers. The company was founded in 1847 and is headquartered in Research Triangle Park, NC. | Technik-/Wissenschafts-/F&E-Leiter | 01.04.2006 | 01.10.2010 |
Schering-Plough Corp.
Schering-Plough Corp. Pharmaceuticals: MajorHealth Technology Schering Plough Corp. manufactures and sells pharmaceuticals, consumer and animal health care products. The firm discovers, develops, manufactures and markets advanced drug therapies. The company is headquartered in Kenilworth, NJ. | Corporate Officer/Principal | 01.01.2006 | 01.01.2006 |
Ausbildung von David Angulo Gonzalez
University of Guadalajara | Doctorate Degree |
Statistik
International
Vereinigte Staaten | 5 |
Mexiko | 2 |
Operativ
Chief Tech/Sci/R&D Officer | 3 |
Corporate Officer/Principal | 1 |
Director/Board Member | 1 |
Sektoral
Health Technology | 5 |
Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
SCYNEXIS, INC. | Health Technology |
Private Unternehmen | 3 |
---|---|
Brickell Subsidiary, Inc.
Brickell Subsidiary, Inc. Pharmaceuticals: MajorHealth Technology Brickell Subsidiary, Inc. operates as a clinical-stage pharmaceutical company. It focuses on the development of differentiated, innovative drug therapies for the treatment of skin diseases. The firm specializes in Hyperhidrosis, Cutaneous T-Cell Lymphoma and Psoriasis areas. The company was founded by Reginald L. Hardy and Andrew D. Sklawer in November 2009 and is headquartered in Boulder, CO. | Health Technology |
Stiefel Laboratories, Inc.
Stiefel Laboratories, Inc. Pharmaceuticals: MajorHealth Technology Stiefel Laboratories, Inc. engages in the manufacture of pharmaceutical products. It offers prescription and non-prescription dermatological and skin care products. The firm research, innovate and develop skin care treatments to health care professionals, patients and consumers. The company was founded in 1847 and is headquartered in Research Triangle Park, NC. | Health Technology |
Schering-Plough Corp.
Schering-Plough Corp. Pharmaceuticals: MajorHealth Technology Schering Plough Corp. manufactures and sells pharmaceuticals, consumer and animal health care products. The firm discovers, develops, manufactures and markets advanced drug therapies. The company is headquartered in Kenilworth, NJ. | Health Technology |
- Börse
- Insiders
- David Angulo Gonzalez
- Erfahrung